Skip to content

VMR-related pain

Prospective cohort on pain after minimal-invasive ventral mesh rectopexy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26985
Enrollment
60
Registered
2019-06-17
Start date
2019-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal prolapse, pelvic organ prolapse

Interventions

Robot-assisted laparoscopic ventral mesh rectopexy (RVMR)

Sponsors

Meander Medical Center, Amersfoort, The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age = 18 years. - Indication for ventral mesh rectopexy (VMR) set by the treating physician in accordance to the current guidelines on rectal prolapse. - Counselled for therapeutic options and given informed consent for robot-assisted VMR (RVMR) or RVMR combined with sacrocolpopexy. - Written informed consent for observational data collection.

Exclusion criteria

Exclusion criteria: - Mentally incompetent patients (unable to fulfil questionnaires). - A medical history of pelvic radiation therapy. - Scheduled for a redo-rectopexy. - A medical history of previously implanted pelvic floor meshes.

Design outcomes

Primary

MeasureTime frame
The difference in pain intensity in the lower back, the lower abdomen and/or the pelvic floor before and six months after RVMR.

Secondary

MeasureTime frame
- To assess differences in quality of pain. - To assess the impact of pain on daily activities. - To investigate if the following parameters are associated with the development of pain after VMR: o The position of the tackers intended on the promontory and the development of new-onset (or worsened) chronic pain in the lower back. o Concomitant sacrocolpopexy o Present complaints of OD o BMI o Comorbidities o Other chronic pain o Emotional functioning

Contacts

Public ContactEmma van der Schans

Meander Medisch Centrum

em.vander.schans@meandermc.nl0338505050

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)